Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia

Huan You Wang, Lily Jun Shen Huang, Zhaoli Liu, Rolando Garcia, Shiyong Li, Carlos A. Galliani

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 1/2-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41% of the cells, and deletion of chromosome 7 and 7q in 37% and 66% of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.

Original languageEnglish (US)
Pages (from-to)749-758
Number of pages10
JournalHuman Pathology
Volume42
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Sarcoma
Leukemia
Bone Marrow
Myeloid Sarcoma
Glycophorin
Literature
Hemoglobin A
Fetal Hemoglobin
Spectrin
Erythroblasts
Chromosomes, Human, Pair 7
Trisomy
Reverse Transcriptase Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Karyotype
Oncogenes
Neoplasms
Biopsy
Population

Keywords

  • Acute erythroid leukemia
  • C-MYB
  • Myeloid sarcoma
  • Pure erythroid leukemia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia. / Wang, Huan You; Huang, Lily Jun Shen; Liu, Zhaoli; Garcia, Rolando; Li, Shiyong; Galliani, Carlos A.

In: Human Pathology, Vol. 42, No. 5, 05.2011, p. 749-758.

Research output: Contribution to journalArticle

Wang, Huan You ; Huang, Lily Jun Shen ; Liu, Zhaoli ; Garcia, Rolando ; Li, Shiyong ; Galliani, Carlos A. / Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia. In: Human Pathology. 2011 ; Vol. 42, No. 5. pp. 749-758.
@article{4b33ae7f97e54b56a594221c00fe1cc5,
title = "Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia",
abstract = "Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 1/2-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41{\%} of the cells, and deletion of chromosome 7 and 7q in 37{\%} and 66{\%} of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.",
keywords = "Acute erythroid leukemia, C-MYB, Myeloid sarcoma, Pure erythroid leukemia",
author = "Wang, {Huan You} and Huang, {Lily Jun Shen} and Zhaoli Liu and Rolando Garcia and Shiyong Li and Galliani, {Carlos A.}",
year = "2011",
month = "5",
doi = "10.1016/j.humpath.2010.08.018",
language = "English (US)",
volume = "42",
pages = "749--758",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia

AU - Wang, Huan You

AU - Huang, Lily Jun Shen

AU - Liu, Zhaoli

AU - Garcia, Rolando

AU - Li, Shiyong

AU - Galliani, Carlos A.

PY - 2011/5

Y1 - 2011/5

N2 - Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 1/2-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41% of the cells, and deletion of chromosome 7 and 7q in 37% and 66% of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.

AB - Pure erythroid leukemia is a rare subtype of acute erythroid leukemia that is characterized by a predominant erythroid population, and erythroblastic sarcoma has not yet been described in the English literature. Here, we report a first case of erythroblastic sarcoma that presented as bilateral ovarian masses in a 3 1/2-month-old infant girl with pure erythroid leukemia. Bone marrow aspirate and biopsy showed that the marrow was completely replaced by large-sized blasts consistent with erythroblasts. Immunophenotypically, both the tumor cells from the ovarian mass and bone marrow blasts were positive for CD117, glycophorin A, and hemoglobin A, demonstrating erythroid differentiation. Reverse transcriptase polymerase chain reaction showed that the tumor cells from ovarian mass expressed hemoglobin F and α1 spectrin, confirming their erythroid lineage. Conventional karyotype of the bone marrow aspirates revealed del(6)(q23q25) and trisomy 7 in all 21 cells examined. Fluorescence in situ hybridization of the ovarian mass demonstrated loss of c-myeloblastosis viral oncogene (C-MYB) at 6q23 locus in 41% of the cells, and deletion of chromosome 7 and 7q in 37% and 66% of cells, respectively. Taken together, we showed, for the first time, that pure erythroid leukemia presented as a myeloid sarcoma in the form of ovarian masses.

KW - Acute erythroid leukemia

KW - C-MYB

KW - Myeloid sarcoma

KW - Pure erythroid leukemia

UR - http://www.scopus.com/inward/record.url?scp=79954598404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954598404&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2010.08.018

DO - 10.1016/j.humpath.2010.08.018

M3 - Article

C2 - 21237494

AN - SCOPUS:79954598404

VL - 42

SP - 749

EP - 758

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 5

ER -